TORONTO—Data management company Unleashed Informatics recently introduced its Unleashed Global Services arm to complement its bioinformatics software and hardware offerings.
Unleashed added the services after noticing how visitors used its portal to explore online products. "What we observed," says Eric Andrade, Unleashed's president and CEO, "was they start out with one product or service that they know and then they begin to explore the notion of integration. It's integration of publicly available sources that is intriguing to them, being able to combine genomics with proteomics."
Data integration, however, is a large task for the small biotechs Unleashed serves. "It's a relationship that these customers require," says Andrade. "They need support introducing a new technology like a data integration platform and blending that with their proprietary data. We were getting that pretty much across the board."
Global Services draws on Unleashed's online databases, analytical and molecular interaction prediction tools, and DogBox Plus, a server equipped with multiple databases and software for integrating Unleashed data with proprietary information. The newest item, DogBox Inside, provides DogBox Plus software minus the server; both products securely maintain data behind the client's firewall.
Unleashed offers two versions of its databases: static, open-source tools plus curated commercial tools available by subscription. Since its launch in March 2006, Unleashed's open-access portal has built a base of 7,000 registered members from academic institutions, large pharmaceutical companies, and small biotech companies.
Unleashed sees startup biotechs and academic labs as its sweet spots. "Those two customer classes have a real need to take the precious dollars that they have and employ them to punch above their weight class," Andrade says.
Colin Aikman, Unleashed's COO, who oversees Global Services, notes that focusing clients to marshal their resources is often a large part of collaboration. Unleashed customizes all services. "I know that every single company is different," he says. "Every single problem is different, and you can't come in with any templated solutions to these problems."
Most Unleashed consultants also worked with the Blueprint Initiative, a public-good research program founded at Toronto's Mt. Sinai Hospital to assemble biomolecular knowledge into what is now Unleashed's Biomolecular Interaction Network Database (BIND). The group raised $29 million and spun off, forming Unleashed; Mt. Sinai retains an undisclosed percentage of the company.